Ready 8-Ks
50
Latest filing
June 23, 2026, 4:33 PM ET
Top materiality
0.85
Event mix
earnings ×19 · leadership ×14 · other_material ×8
Sentiment
4 pos · 15 neg · 31 neu
Latest earnings
reported 2026-Q3
-
Conagra appoints John Brase as President and CEO, succeeding Sean Connolly effective June 1, 2026
John Brase, former Smucker COO, named CEO and Board member; effective June 1, 2026.
-
Conagra Q3 organic sales +2.4% but adjusted EPS -23.5%; narrows FY guidance to low end
Reported net sales $2.8B (-1.9% YoY); organic net sales +2.4% (price/mix +1.9%, volume +0.5%).
-
Conagra Q2 net loss $664M ($1.39 diluted loss) on $968M impairment; adjusted EPS $0.45
Net sales fell 6.8% to $3.0B; organic net sales declined 3.0% with volume down 3.0%.
-
Conagra Q1 EPS $0.34 (-64.9% YoY); adj EPS $0.39; reaffirms FY26 guidance
Net sales $2.6B, down 5.8% YoY; organic net sales down 0.6%, volume down 1.2%.
-
Conagra Brands closes $1B dual-tranche senior notes offering
$500M of 5.000% Senior Notes due 2030 and $500M of 5.750% Senior Notes due 2035 issued.
-
Conagra Q4 net sales down 4.3%, adjusted EPS $0.56; FY2026 guidance weak
Q4 net sales $2.8B, down 4.3% (organic -3.5%); adjusted EPS $0.56 vs $0.61 prior year (down 8.2%).
-
Conagra sells Chef Boyardee shelf-stable business to Hometown Food for $600M
Sale price $600M cash; business contributed ~$450M net sales in FY2024.
-
Conagra Q3 adjusted EPS $0.51 (down 26%), net sales $2.8B (down 6.3%); guidance reaffirmed
Reported EPS $0.30 (down 53%); adjusted EPS $0.51 (down 26%); both below prior year.
-
Conagra cuts FY2025 EPS guidance to ~$2.35 on supply constraints, FX headwinds
Organic net sales growth revised from near (1.5%)–flat to ~(2.0%) vs FY24.
-
Conagra Q2 organic sales up 0.3%; adj. EPS $0.70, down 1.4%; updates FY25 guidance lower
Reported net sales -0.4% to $3.2B; organic net sales +0.3% driven by volume +0.4%.
-
Conagra Q1 adj. EPS down 19.7%; organic sales -3.5%; reaffirms FY2025 guidance
Reported net sales $2.8B, -3.8%; organic net sales -3.5%; volume -1.6%, price/mix -1.9%.
-
Conagra shareholders reject say-on-pay; approve officer exculpation charter amendment
Say-on-pay failed: 206.2M against (55.3%), 166.7M for, 1.2M abstain; 49.1M broker non-votes.
-
Conagra Q4 reports $1.18 loss per share on $957M impairment; adjusted EPS $0.61; FY2025 guidance issued
Q4 reported net sales down 2.3% to $2.9B; reported diluted EPS loss of $1.18, adjusted EPS $0.61.
-
Conagra Q3: net sales $3.0B (-1.7%), adjusted EPS $0.69 (-9.2%), reaffirms FY guidance
Net sales $3.0B, down 1.7% YoY; organic net sales down 2.0% on volume decline of 1.8%.
-
Conagra Q3 adjusted EPS $0.69, down 9.2%; FY guidance reaffirmed
Net sales $3.0B, down 1.7% vs prior year; organic net sales down 2.0%.
-
Conagra Q2 EPS falls 24.1% to $0.60; cuts FY2024 guidance on slower volume recovery
Net sales $3.2B, down 3.2% YoY; organic net sales down 3.4% driven by 2.9% volume decline and 0.5% price/mix decrease.
-
Conagra Q1 adjusted EPS $0.66, +15.8% YoY; reaffirms FY2024 outlook
Net sales flat at $2.9B; organic net sales -0.3% (volume -6.6%, price/mix +6.3%).
-
Conagra Q4 adj. EPS falls 4.6% to $0.62; dividend raised 6% to $1.40/share
Q4 GAAP EPS $0.08 (down 75.8% YoY) on $3.0B net sales (+2.2% organic); price/mix +9.9%, volume -7.7%.
-
Conagra Q3 EPS $0.71 beats; raises FY2023 adjusted EPS guidance to $2.70-$2.75
Q3 net sales $3.1B (+5.9% YoY); organic net sales +6.1%; adjusted EPS $0.76 (+31%).
-
Conagra Q2 adj EPS $0.81 beats, net sales +8.3%; raises FY2023 guidance
Diluted EPS $0.79 (+38.6%), adjusted EPS $0.81 (+26.6%); net sales $3.3B (+8.3% organic +8.6%).
-
Conagra Q1: adjusted EPS $0.57 beats; GAAP loss $0.16 on $386M impairment; reaffirms FY outlook
Net sales $2.9B (+9.5% YoY); organic net sales +9.7% driven by 14.3% price/mix partially offset by 4.6% volume decline.
-
Conagra Q4 adj EPS up 20.4% to $0.65; full-year EPS down 30.8%; guides FY23 adj EPS growth 1-5%
Q4 net sales +6.2% to $2.9B; organic net sales +6.8% driven by price/mix +13.2% offset by volume -6.4%.